340B Drug Pricing Program
The AHA July 26 submitted a letter expressing concerns in response to the recently introduced 340B Affording Care for Communities and Ensuring a Strong Safety-Net (340B ACCESS) Act.
The American Hospital Association (AHA) expresses their opposition to H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net (340B ACCESS) Act.
Monument Health is the largest health care provider in western South Dakota. It is an integral part of the local community, providing a wide array of vital services including behavioral health, oncology and dialysis care.
The AHA, 340B Health, Maryland Hospital Association and Mid-Atlantic Association of Community Health Centers July 9 filed an amicus brief in a federal district court in Maryland, defending the state’s law protecting 340B pricing for contract pharmacy arrangements.
AHA, others file briefs in Maryland, West Virginia to prevent injunctions against 340B pricing for contract pharmacy arrangements
AHA et al Amicus Brief to Prevent Injunction Against 340B Pricing for Contract Pharmacy Arrangements in Novartis v. Morrissey Litigation
UNITED STATES DISTRICT COURTFOR THE SOUTHERN DISTRICT OF DISTRICT OF WEST VIRGINIA
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed concern about the agency’s proposal to retrospectively effectuate the policy.
AHA shares feedback on the Centers for Medicare & Medicaid Services’ draft guidance on the Medicare drug price negotiation program.
A Mississippi judge yesterday denied Novartis Pharmaceuticals’ and PhRMA’s request for a preliminary injunction against enforcement of state law protecting 340B pricing for contract pharmacy arrangements.